BioSpace News Archive

Reven Holdings, Inc. (“Reven”), today announced the publication of two peer-reviewed expert articles authored by its Chief Medical Officer & Chief Scientific Officer, Fatih Uckun M.D. Ph.D., and other members of the Reven team and their academic collaborators in the medical journal, Clinical Investigation (London).

Turner Imaging Systems has entered into a Master Resellers agreement which will add the Smart-C® Mini C-Arm to the Siemens Healthineers portfolio of radiology and imaging products. With this agreement, Siemens Healthineers becomes the premium partner reseller to the hospital market and will focus on delivering the Smart-C to their hospital, IDN, GPO and military customers in the United States. International expansion will al

Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases, today announced the appointment of Robert Richard, Ph.D., to the position of Senior Vice President of Research and Development. He is a research and development (R&D) veteran who possesses ex

NS Pharma, Inc., a wholly owned subsidiary of Nippon Shinyaku Co., Ltd., announced the launch of NS Support for patients with Duchenne muscular dystrophy and their healthcare providers.

Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma components intended for transfusion. These data are consistent with prior INTERCEPT studies showing complete inactivation, to below the limit of detection, of other coronaviruses associated with severe pulmonary disease: MERS-CoV 1,2 (2018, 2019) a

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX ), a clinical-stage biomedical company, provides the following update regarding upcoming news in its Dry Eye Disease Program. Dry Eye Disease (DED) – ProtoKinetix is expecting closure of agreements for the first steps in a roll-out of a new product line development that will

StemSation International, Inc. (OTC PINK:STSN) - a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces it has filed a Statement of Use on four separate trademarks on which the US Patent & Trademark Office has granted a Notice of Allowance . StemSation, through its wholly-owned subsidiary, StemSation IP Holding LLC, plans to build a valuable portfolio of intellectual property, to include patents, tra

Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its partner, Premas Biotech, the initiation of animal studies for its SARS-CoV-2 vaccine candidate in India. Premas has successfully completed the manufacturing process for the VLP (virus like particle) vaccine candidate, including th

Medtronic plc (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps 1 . The MiniMed Mio Advance infusion set is inserted in only four steps — individ

The Parkinson’s Foundation today announced the preliminary results from the PD GENEration: Mapping the Future of Parkinson’s Disease pilot study. PD GENEration is a first-of-its kind national initiative that offers fr